Title:
MxAタンパク質の多型遺伝子およびその使用
Document Type and Number:
Japanese Patent JP3983985
Kind Code:
B2
Abstract:
The present invention provides polynucleotides having base sequences of sequence Nos. 1 to 4, as polynucleotides having polymorphism sites capable of being useful indicators for prediction of validity of interferon therapy.
Inventors:
Minako Hijikata
Shunji Midai
Hirohiko Ota
Koji Hashimoto
Shunji Midai
Hirohiko Ota
Koji Hashimoto
Application Number:
JP2001062371A
Publication Date:
September 26, 2007
Filing Date:
March 06, 2001
Export Citation:
Assignee:
Toshiba Corporation
International Classes:
A01K67/027; A61K31/7088; C12N15/09; A61K35/76; A61K48/00; A61P15/00; A61P25/00; A61P27/02; A61P27/16; A61P31/12; A61P31/20; A61P31/22; A61P35/00; A61P35/02; A61P43/00; C12N5/10; C12N15/11; C12Q1/68; C12Q1/6837; C12Q1/6883; C12Q1/6886; C12Q1/70
Other References:
J. Interferon Cytokine Res., 18(1998) p.773-781
Arch. Virol., 117(1991) p.1-15
J. Interferon Cytokine Res., 19(1999) p.243-251
FEBS Letters, 418(1997) p.315-318
Arch. Virol., 117(1991) p.1-15
J. Interferon Cytokine Res., 19(1999) p.243-251
FEBS Letters, 418(1997) p.315-318
Attorney, Agent or Firm:
Takehiko Suzue
Sadao Muramatsu
Ryo Hashimoto
Satoshi Kono
Makoto Nakamura
Shoji Kawai
Sadao Muramatsu
Ryo Hashimoto
Satoshi Kono
Makoto Nakamura
Shoji Kawai